Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

MELLO

MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
2019
1-10
Copenhagen, Hovedstaden, Denmark
  • Drug Delivery and Devices
  • Nutraceuticals (e.g. Supplements)
  • Probiotics

Investment Funding

Last Funding Stage

Convertible Note

Total Funding Amount

548.38K

Last Funding Date

16-03-2023

Lead Investors

BioInnovation Institute, BioInnovation Institute Venture House

Something missing or incorrect on this page? Help us enrich this information